Jasper van der Aart

535 total citations
16 papers, 359 citations indexed

About

Jasper van der Aart is a scholar working on Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Jasper van der Aart has authored 16 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 7 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Jasper van der Aart's work include Neuroscience and Neuropharmacology Research (7 papers), Medical Imaging Techniques and Applications (6 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Jasper van der Aart is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Medical Imaging Techniques and Applications (6 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Jasper van der Aart collaborates with scholars based in United Kingdom, Netherlands and United States. Jasper van der Aart's co-authors include Eugenii A. Rabiner, Roger N. Gunn, Marc Laruelle, Sergio Abanades, Graham E. Searle, Christian Grillon, Floris Klumpers, Damiaan Denys, Johanna M.P. Baas and J. Leon Kenemans and has published in prestigious journals such as NeuroImage, Journal of Pharmacology and Experimental Therapeutics and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Jasper van der Aart

16 papers receiving 358 citations

Peers

Countries citing papers authored by Jasper van der Aart

Since Specialization

Citations

This map shows the geographic impact of Jasper van der Aart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasper van der Aart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasper van der Aart more than expected).

Fields of papers citing papers by Jasper van der Aart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasper van der Aart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasper van der Aart. The network helps show where Jasper van der Aart may publish in the future.

Co-authorship network of co-authors of Jasper van der Aart

This figure shows the co-authorship network connecting the top 25 collaborators of Jasper van der Aart. A scholar is included among the top collaborators of Jasper van der Aart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasper van der Aart. Jasper van der Aart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non‐small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study 2023 ·Clinical and Translational Science ·Simon Ekman, Zsolt Cselényi, Andrea Varrone, Aurelija Jučaitė, (unknown), Magnus Schou, Peter Johnström, Gianluca Laus, Rolf Lewensohn, Andy Brown, Jasper van der Aart, Karthick Vishwanathan, Lars Farde	7
2	The role of clinical imaging in oncology drug development: progress and new challenges 2023 ·British Journal of Radiology ·Philip S. Murphy, (unknown), Jasper van der Aart, Robert L. Janiczek, (unknown), Andy Brown	1
3	Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects 2021 ·Drugs in R&D ·C. J. G. Bakker, Jasper van der Aart, Geert Labots, (unknown), David M. Cross, Erica S. Klaassen, Stephen J. Dickinson, Tim Tasker, Geert Jan Groeneveld	5
4	Safety, pharmacokinetics, and pharmacodynamics of Gln‐1062, a prodrug of galantamine 2020 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·C. J. G. Bakker, Jasper van der Aart, Ellen P. Hart, Erica S. Klaassen, (unknown), Michiel J. van Esdonk, Denis G. Kay, Geert Jan Groeneveld	16
5	Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial 2020 ·Journal of Psychopharmacology ·(unknown), Jasper van der Aart, Gabriël E. Jacobs, Marieke de Kam, Wayne C. Drevets, Luc Van Nueten, (unknown), Pieter Siebenga, Rob Zuiker, Paulien Ravenstijn, Maarten Timmers, Joop van Gerven, Peter de Boer	44
6	First in human evaluation of [18F]PK-209, a PET ligand for the ion channel binding site of NMDA receptors 2018 ·EJNMMI Research ·Jasper van der Aart, Sandeep S.V. Golla, (unknown), Lothar A. Schwarte, Robert C. Schuit, (unknown), Athanasios Metaxas, Albert D. Windhorst, Ronald Boellaard, Adriaan A. Lammertsma, Bart N.M. van Berckel	10
7	Evaluation of the Novel PET Tracer [11C]HACH242 for Imaging the GluN2B NMDA Receptor in Non-Human Primates 2018 ·Molecular Imaging and Biology ·Jasper van der Aart, Maqsood Yaqub, Esther Kooijman, Jaco Bakker, Jan A. M. Langermans, Robert C. Schuit, Mark B.M. Hofman, Johannes A. M. Christiaans, Adriaan A. Lammertsma, Albert D. Windhorst, Bart N.M. van Berckel	4
8	Human Dosimetry of the N-Methyl-d-Aspartate Receptor Ligand ¹¹C-GMOM 2017 ·Journal of Nuclear Medicine ·Jasper van der Aart, Thalia F. van der Doef, (unknown), Marc C. Huisman, Robert C. Schuit, Arthur van Lingen, Albert D. Windhorst, Bart N.M. van Berckel, Adriaan A. Lammertsma	1
9	Quantification of human brain PDE4 occupancy by GSK356278: A [¹¹C](R)-rolipram PET study 2017 ·Journal of Cerebral Blood Flow & Metabolism ·Jasper van der Aart, Cristian Salinas, (unknown), (unknown), (unknown), (unknown), (unknown), Jan Passchier, Roger N. Gunn, Eugenii A. Rabiner	8
10	In vivo occupancy of the 5-HT1A receptor by a novel pan 5-HT1(A/B/D) receptor antagonist, GSK588045, using positron emission tomography 2014 ·Neuropharmacology ·Robert A. Comley, Jasper van der Aart, Balázs Gulyás, Martine Garnier, Laura Iavarone, Christer Halldin, Eugenii A. Rabiner	2
11	Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography 2013 ·Journal of Pharmacology and Experimental Therapeutics ·Robert A. Comley, Cristian Salinas, Mark Slifstein, Marcella Petrone, (unknown), Idriss Bennacef, Paul Shotbolt, Jasper van der Aart, (unknown), Laura Iavarone, Roberto Goméni, Marc Laruelle, (unknown), Roger N. Gunn, Eugenii A. Rabiner	15
12	Testing the effects of Δ9-THC and D-cycloserine on extinction of conditioned fear in humans 2012 ·Journal of Psychopharmacology ·Floris Klumpers, Damiaan Denys, J. Leon Kenemans, Christian Grillon, Jasper van der Aart, Johanna M.P. Baas	60
13	Radiation dose estimates for carbon-11-labelled PET tracers 2011 ·Nuclear Medicine and Biology ·Jasper van der Aart, William Hallett, Eugenii A. Rabiner, Jan Passchier, Robert A. Comley	36
14	Within-Subject Comparison of [¹¹C]-( + )-PHNO and [¹¹C]raclopride Sensitivity to Acute Amphetamine Challenge in Healthy Humans 2011 ·Journal of Cerebral Blood Flow & Metabolism ·Paul Shotbolt, Andri C. Tziortzi, Graham E. Searle, Alessandro Colasanti, Jasper van der Aart, Sergio Abanades, Christophe Plisson, Sam R. Miller, Mickaël Huiban, John D. Beaver, Roger N. Gunn, Marc Laruelle, Eugenii A. Rabiner	104
15	Within-subject comparison of the sensitivity of [11C]-(+)-PHNO and [11C]raclopride to amphetamine induced changes in endogenous dopamine in healthy human volunteers 2010 ·NeuroImage ·Paul Shotbolt, Andri C. Tziortzi, Sam Miller, Graham E. Searle, Jasper van der Aart, Sergio Abanades, Christophe Plisson, Mickaël Huiban, John D. Beaver, Roger N. Gunn, Marc Laruelle, Eugenii A. Rabiner	1
16	Prediction of Repeat-Dose Occupancy from Single-Dose Data: Characterisation of the Relationship between Plasma Pharmacokinetics and Brain Target Occupancy 2010 ·Journal of Cerebral Blood Flow & Metabolism ·Sergio Abanades, Jasper van der Aart, Julien Barletta, (unknown), Graham E. Searle, Cristian Salinas, (unknown), (unknown), (unknown), Stefano Zamuner, Vincent J. Cunningham, Eugenii A. Rabiner, Marc Laruelle, Roger N. Gunn	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact